GNLX:NASDAQ
Genelux Corp
US$ २.४९
arrow_downward
-१.१९%(-०.०३०) 1D
अक्टोबर १४, ०९:३४:०८ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNLX...
Open
US$ २.४८
High
US$ २.४९
Low
US$ २.४८
Mkt. cap
११.२७ करोड
Avg. vol.
२.४३ लाख
Volume
४.२४ हजार
52-wk high
US$ ८.५४
52-wk low
US$ २.२९
EPS
-US$ ०.८७
Beta
०.५९
Shares outstanding
४.५२ करोड
No. of employees
२६
Open
US$ २.४८
High
US$ २.४९
Low
US$ २.४८
Mkt. cap
११.२७ करोड
Avg. vol.
२.४३ लाख
Volume
४.२४ हजार
52-wk high
US$ ८.५४
52-wk low
US$ २.२९
EPS
-US$ ०.८७
Beta
०.५९
Shares outstanding
४.५२ करोड
No. of employees
२६
News stories
From web sources and news partners
PR Newswire UK
·
४२ मिनेट पहिले
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
Central Oregon Daily
·
१९ मिनेट पहिले
Wall St set for lower open as hot inflation data fuels rate-hike bets
GlobeNewswire
·
१ घण्टा पहिले
Delixy Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance
·
१ घण्टा पहिले
33-Year History Shows How to Profit Even When a Market Crash Hits
Profile
Genelux Corporation is a publicly traded late clinical-stage company developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus with a large engineering capacity.
The core of Genelux’s discovery and development efforts revolves around the company's proprietary CHOICE™ platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec.
The company is currently entered its pivot Phase 3 study in Platinum resistant/refractory ovarian cancer. Trial design based on VIRO-15 Phase 2 trial which showed independent anti-tumor activity of Olvi-Vec and reversal of platinum resistance in the TME. Wikipedia
About Genelux Corp
CEO-
Employees२६
Founded२००१
HeadquartersWestlake Village, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitegenelux.com